Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
Kuldeep Dhama, Shailesh Kumar Patel, Mamta Pathak, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101755-101755
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Coronavirus Disease 2019–COVID-19
Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 4
Open Access | Times Cited: 1786
An Update on Current Therapeutic Drugs Treating COVID-19
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
The Novel Coronavirus (nCoV)
Július Rajčáni
Microbiology & Infectious Diseases (2021) Vol. 5, Iss. 3
Open Access | Times Cited: 318
COVID-19: animals, veterinary and zoonotic links
Ruchi Tiwari, Kuldeep Dhama, Khan Sharun, et al.
Veterinary Quarterly (2020) Vol. 40, Iss. 1, pp. 169-182
Open Access | Times Cited: 274
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
David N. Juurlink
Canadian Medical Association Journal (2020) Vol. 192, Iss. 17, pp. E450-E453
Open Access | Times Cited: 237
SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus
Kuldeep Dhama, Shailesh Kumar Patel, Khan Sharun, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101830-101830
Open Access | Times Cited: 223
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
Ali A. Rabaan, Shamsah H. Al-Ahmed, Javed Muhammad, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 436-436
Open Access | Times Cited: 218
Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19
Ali A. Rabaan, Raghavendra Tirupathi, Anupam Sule, et al.
Diagnostics (2021) Vol. 11, Iss. 6, pp. 1091-1091
Open Access | Times Cited: 191
Covid‐19 and dengue: Double punches for dengue‐endemic countries in Asia
Harapan Harapan, Mirza Ryan, Benediktus Yohan, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 2
Open Access | Times Cited: 187
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
Victoria Callahan, Seth A. Hawks, Matthew A. Crawford, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1062-1062
Open Access | Times Cited: 118
Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis
Endang Mutiawati, Marhami Fahriani, Sukamto S. Mamada, et al.
F1000Research (2021) Vol. 10, pp. 40-40
Open Access | Times Cited: 113
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, et al.
Annals of Clinical Microbiology and Antimicrobials (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 134
Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity
José João Name, Ana Carolina Remondi Souza, Añdrea Rodrigues Vasconcelos, et al.
Frontiers in Nutrition (2020) Vol. 7
Open Access | Times Cited: 98
Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond
Kuldeep Dhama, Shailesh Kumar Patel, Rakesh Kumar, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 94
Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia
Miaobo Ye, Guiwen Luo, Dexiao Ye, et al.
Phytomedicine (2020) Vol. 85, pp. 153401-153401
Open Access | Times Cited: 84
Burnout levels and sleep quality of COVID‐19 heroes
Aylin Aydın Sayılan, Nurşen Kulakaç, Sevda Uzun
Perspectives In Psychiatric Care (2020) Vol. 57, Iss. 3, pp. 1231-1236
Open Access | Times Cited: 84
Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
Synat Keam, Dewi Megawati, Shailesh Kumar Patel, et al.
Reviews in Medical Virology (2020) Vol. 30, Iss. 5
Open Access | Times Cited: 83
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
Choongho Lee, Won Jun Choi
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 99-116
Open Access | Times Cited: 83
Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation
Steven Andrew Baker, Shirley Kwok, Gerald J. Berry, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0247060-e0247060
Open Access | Times Cited: 82
AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal
Ranjit Sah, Sunil Shrestha, Rachana Mehta, et al.
Travel Medicine and Infectious Disease (2021) Vol. 40, pp. 101989-101989
Open Access | Times Cited: 80
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
Ali A. Rabaan, Shamsah H. Al-Ahmed, Mohammed Garout, et al.
Pathogens (2021) Vol. 10, Iss. 5, pp. 565-565
Open Access | Times Cited: 73
TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
Gillina F. G. Bezemer, Johan Garssen
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 66
SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic
Ranjan K. Mohapatra, Satwik Kuppili, Tarun Kumar Suvvari, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 5, pp. 769-788
Open Access | Times Cited: 58
Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis
Syahrul Syahrul, Helnida Anggun Maliga, Muhammad Ilmawan, et al.
F1000Research (2021) Vol. 10, pp. 34-34
Open Access | Times Cited: 55
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
Mohd. Iqbal Yatoo, Zeenat Hamid, Oveas Rafiq Parray, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2891-2904
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top